New study explores whether stem cells from bone marrow or blood offer transplant patients better quality of life
Aug. 16, 2016
| By Susan Keown / Fred Hutch News Service
A new study of blood stem-cell transplant patients found no difference in survival between patients who received transplants derived from bone marrow versus those who received transplants derived from circulating blood stem-cells. However, the bone marrow transplant patients did experience fewer related symptoms and side effects.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.